UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
NCT00111748
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Velcade, Thalidomide, Dexamethasone
Sponsor
University of Arkansas